Michael Venning

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

David Jayne, Annette Bruchfeld, Lorraine Harper et al. · Journal of the American Society of Nephrology · 2017 · 590 citations · Full text

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

Durga Kanigicherla, Jennet Gummadova, Edward A. McKenzie et al. · Kidney International · 2013 · 340 citations

Glomerular Disease, Glomerulonephritis, Renal Function +11

Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell Recognition

Anna Richards, M. Buddles, Rosemary L. Donne et al. · The American Journal of Human Genetics · 2001 · 310 citations · Full text

Exons 18–20, Genetic Disorder, Factor H Mutations +9

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

Eleana Ntatsaki, David Carruthers, Kuntal Chakravarty et al. · Lara D. Veeken · 2014 · 289 citations · Full text

Interstitial myofibroblasts: predictors of progression in membranous nephropathy.

S. A. Roberts, Colin F. Burrows, Jonathan H. Shanks et al. · Journal of Clinical Pathology · 1997 · 139 citations · Full text